Chronic myeloid leukemia — before and after imatinib (First part)
The first successful experience effective target therapy has been achieved at imatinib administration in chronic myeloid leukemia (CML) treatment. Disease early considered practically incurable, now successful controlled using little toxic conservative therapy. During tyrosine kinase inhibitors ther...
| मुख्य लेखकों: | , , , |
|---|---|
| स्वरूप: | लेख |
| भाषा: | Russian |
| प्रकाशित: |
ABV-press
2022-11-01
|
| श्रृंखला: | Онкогематология |
| विषय: | |
| ऑनलाइन पहुंच: | https://oncohematology.abvpress.ru/ongm/article/view/721 |